Literature DB >> 34083219

HLA Alleles and Prognosis of PLA2R-Related Membranous Nephropathy.

Wei-Bo Le1, Jing-Song Shi2, Yang Fan2, Si-Wen Gong3.   

Abstract

BACKGROUND AND OBJECTIVES: Associations between HLA alleles and susceptibility to M-type phospholipase A2 receptor (PLA2R)-related membranous nephropathy have been well defined previously in Chinese patients. However, the relationships between HLA alleles and kidney outcome remain unclear. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Five HLA genes (DRB1, DQA1, DQB1, DRB3, and DRB5) were genotyped in a prospective cohort of 392 patients with PLA2R-related membranous nephropathy. The associations between HLA alleles and kidney outcomes were studied.
RESULTS: A total of 79 HLA alleles were identified in this study. Four HLA alleles, DRB1*13:01 (n=12; hazard ratio, 3.7; 95% confidence interval, 1.8 to 7.8; P<0.001), DQB1*06:03 (n=12; hazard ratio, 3.7; 95% confidence interval, 1.8 to 7.8; P<0.001), DRB1*04:05 (n=12; hazard ratio, 3.8; 95% confidence interval, 1.5 to 9.5; P=0.004), and DQB1*03:02 (n=21; hazard ratio, 3.1; 95% confidence interval, 1.4 to 6.7; P=0.005), were associated with a ≥40% eGFR decline during follow-up. DRB1*13:01 and DQB1*06:03 were tightly linked with each other. Forty-four of the 392 patients (11%) carried at least one of the four identified risk HLA alleles in this study. Compared with patients who were negative for all risk HLA alleles, those carrying at least one risk HLA allele had a significant risk of a ≥40% eGFR decline during follow-up (hazard ratio, 3.9; 95% confidence interval, 2.3 to 6.7; P<0.001). After adjusting for age, sex, proteinuria, albumin, eGFR, and anti-PLA2R antibody levels, multivariable Cox analysis showed that patients carrying any of the four risk HLA alleles remained associated with a higher risk of a ≥40% decline in eGFR (hazard ratio, 4.1; 95% confidence interval, 2.3 to 7.1; P<0.001).
CONCLUSIONS: Carrying any of the HLA alleles, DRB1*13:01/DQB1*06:03, DRB1*04:05, and DQB1*03:02, was independently associated with poor prognosis in Chinese patients with PLA2R-related membranous nephropathy.
Copyright © 2021 by the American Society of Nephrology.

Entities:  

Keywords:  HLA; PLA2R; genetics; glomerular disease; haplotypes; membranous nephropathy; prognosis

Mesh:

Substances:

Year:  2021        PMID: 34083219      PMCID: PMC8455041          DOI: 10.2215/CJN.18021120

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   10.614


  26 in total

1.  Distribution of human leucocyte antigen-A, -B and -DR alleles and haplotypes at high resolution in the population from Jiangsu province of China.

Authors:  P Qin Qin; F Su; W Xiao Yan; Z Xing; P Meng; W Chengya; S Jie
Journal:  Int J Immunogenet       Date:  2011-08-05       Impact factor: 1.466

2.  Anti-phospholipase A2 receptor antibody in membranous nephropathy.

Authors:  Weisong Qin; Laurence H Beck; Caihong Zeng; Zhaohong Chen; Shijun Li; Ke Zuo; David J Salant; Zhihong Liu
Journal:  J Am Soc Nephrol       Date:  2011-05-12       Impact factor: 10.121

3.  PLA2R-associated membranous glomerulopathy is modulated by common variants in PLA2R1 and HLA-DQA1 genes.

Authors:  M Saeed; M L Beggs; P D Walker; C P Larsen
Journal:  Genes Immun       Date:  2014-09-04       Impact factor: 2.676

Review 4.  A Proposal for a Serology-Based Approach to Membranous Nephropathy.

Authors:  An S De Vriese; Richard J Glassock; Karl A Nath; Sanjeev Sethi; Fernando C Fervenza
Journal:  J Am Soc Nephrol       Date:  2016-10-24       Impact factor: 10.121

5.  HLA-A, -B and -DRB1 genotyping and haplotype frequencies of 3892 cord blood units in the Hong Kong Chinese Cord Blood Registry.

Authors:  Janette Kwok; Mengbiao Guo; Wanling Yang; C K Lee; N K Chan; Jenny Ho; W H Tang; Y S Chan; Derek Middleton; L W Lu; Godfrey C F Chan
Journal:  Hum Immunol       Date:  2016-10-18       Impact factor: 2.850

6.  HLA class II alleles differing by a single amino acid associate with clinical phenotype and outcome in patients with primary membranous nephropathy.

Authors:  Huai-Yu Wang; Zhao Cui; Li-Jun Xie; Li-Jie Zhang; Zhi-Yong Pei; Fang-Jin Chen; Zhen Qu; Jing Huang; Yi-Miao Zhang; Xin Wang; Fang Wang; Li-Qiang Meng; Xu-Yang Cheng; Gang Liu; Xu-Jie Zhou; Hong Zhang; Hanna Debiec; Pierre Ronco; Ming-Hui Zhao
Journal:  Kidney Int       Date:  2018-08-30       Impact factor: 10.612

7.  HLA-DRB1*15:01 and HLA-DRB3*02:02 in PLA2R-Related Membranous Nephropathy.

Authors:  Wei-Bo Le; Jing-Song Shi; Tao Zhang; Lei Liu; Hua-Zhang Qin; ShaoShan Liang; Yuan-Wei Zhang; Cun-Xia Zheng; Song Jiang; Wei-Song Qin; Hai-Tao Zhang; Zhi-Hong Liu
Journal:  J Am Soc Nephrol       Date:  2016-12-27       Impact factor: 10.121

8.  Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China.

Authors:  Xin Xu; Guobao Wang; Nan Chen; Tao Lu; Sheng Nie; Gang Xu; Ping Zhang; Yang Luo; Yongping Wang; Xiaobin Wang; Joel Schwartz; Jian Geng; Fan Fan Hou
Journal:  J Am Soc Nephrol       Date:  2016-06-30       Impact factor: 10.121

9.  High-density Association Mapping and Interaction Analysis of PLA2R1 and HLA Regions with Idiopathic Membranous Nephropathy in Japanese.

Authors:  Myo Thiri; Kenjiro Honda; Koichi Kashiwase; Akihiko Mabuchi; Hodaka Suzuki; Kimio Watanabe; Masaaki Nakayama; Tsuyoshi Watanabe; Kent Doi; Katsushi Tokunaga; Eisei Noiri
Journal:  Sci Rep       Date:  2016-12-09       Impact factor: 4.379

10.  The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis.

Authors:  Jingyuan Xie; Lili Liu; Nikol Mladkova; Yifu Li; Hong Ren; Weiming Wang; Zhao Cui; Li Lin; Xiaofan Hu; Xialian Yu; Jing Xu; Gang Liu; Yasar Caliskan; Carlo Sidore; Olivia Balderes; Raphael J Rosen; Monica Bodria; Francesca Zanoni; Jun Y Zhang; Priya Krithivasan; Karla Mehl; Maddalena Marasa; Atlas Khan; Fatih Ozay; Pietro A Canetta; Andrew S Bomback; Gerald B Appel; Simone Sanna-Cherchi; Matthew G Sampson; Laura H Mariani; Agnieszka Perkowska-Ptasinska; Magdalena Durlik; Krzysztof Mucha; Barbara Moszczuk; Bartosz Foroncewicz; Leszek Pączek; Ireneusz Habura; Elisabet Ars; Jose Ballarin; Laila-Yasmin Mani; Bruno Vogt; Savas Ozturk; Abdülmecit Yildiz; Nurhan Seyahi; Hakki Arikan; Mehmet Koc; Taner Basturk; Gonca Karahan; Sebahat Usta Akgul; Mehmet Sukru Sever; Dan Zhang; Domenico Santoro; Mario Bonomini; Francesco Londrino; Loreto Gesualdo; Jana Reiterova; Vladimir Tesar; Claudia Izzi; Silvana Savoldi; Donatella Spotti; Carmelita Marcantoni; Piergiorgio Messa; Marco Galliani; Dario Roccatello; Simona Granata; Gianluigi Zaza; Francesca Lugani; GianMarco Ghiggeri; Isabella Pisani; Landino Allegri; Ben Sprangers; Jin-Ho Park; BeLong Cho; Yon Su Kim; Dong Ki Kim; Hitoshi Suzuki; Antonio Amoroso; Daniel C Cattran; Fernando C Fervenza; Antonello Pani; Patrick Hamilton; Shelly Harris; Sanjana Gupta; Chris Cheshire; Stephanie Dufek; Naomi Issler; Ruth J Pepper; John Connolly; Stephen Powis; Detlef Bockenhauer; Horia C Stanescu; Neil Ashman; Ruth J F Loos; Eimear E Kenny; Matthias Wuttke; Kai-Uwe Eckardt; Anna Köttgen; Julia M Hofstra; Marieke J H Coenen; Lambertus A Kiemeney; Shreeram Akilesh; Matthias Kretzler; Lawrence H Beck; Benedicte Stengel; Hanna Debiec; Pierre Ronco; Jack F M Wetzels; Magdalena Zoledziewska; Francesco Cucca; Iuliana Ionita-Laza; Hajeong Lee; Elion Hoxha; Rolf A K Stahl; Paul Brenchley; Francesco Scolari; Ming-Hui Zhao; Ali G Gharavi; Robert Kleta; Nan Chen; Krzysztof Kiryluk
Journal:  Nat Commun       Date:  2020-03-30       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.